{"id":61036,"date":"2016-04-26T13:39:03","date_gmt":"2016-04-26T13:39:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=61036"},"modified":"2016-04-26T13:39:03","modified_gmt":"2016-04-26T13:39:03","slug":"alzheimers-disease-industrymarket-sizegrowthtrends-and-2016-forecast-report-radiant-insights-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/alzheimers-disease-industrymarket-sizegrowthtrends-and-2016-forecast-report-radiant-insights-inc_61036.html","title":{"rendered":"Alzheimer\\’s Disease Industry, Market Size, Growth, Trends and 2016 Forecast Report: Radiant Insights, Inc"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Radiant Insights”<\/div>\n<\/div>\n<\/div>\n
Research Report On “Alzheimer’s Disease” The report provides comprehensive information on the therapeutics under development for Alzheimer’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.<\/div>\n

Deep Research on “Alzheimer’s Disease” Global Markets Direct’s, ‘Alzheimer’s Disease – Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company\/university websites.<\/p>\n

Access Detail Report with TOC @<\/strong><\/p>\n

http:\/\/www.radiantinsights.com\/research\/alzheimer-s-disease-pipeline-review-h1-2016<\/a><\/p>\n

Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.<\/p>\n

Related Reports On “Pharmaceuticals & Healthcare”<\/strong><\/p>\n

House Dust Mite Allergy – Pipeline Review, H1 2015 :<\/strong>
http:\/\/www.radiantinsights.com\/research\/house-dust-mite-allergy-pipeline-review-h1-2015<\/a><\/p>\n

Japan Tissue Expanders Industry 2016 Market Research Report :<\/strong>
http:\/\/www.radiantinsights.com\/research\/japan-tissue-expanders-industry-2016<\/a><\/p>\n

Japan Testicular Implants Industry 2016 Market Research Report:<\/strong>
http:\/\/www.radiantinsights.com\/research\/japan-testicular-implants-industry-2016<\/a><\/p>\n

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.<\/p>\n

About Radiant Insights<\/strong><\/p>\n

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships\/ tie-ups and customized research solutions.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Radiant Insights, Inc.
Contact Person:<\/strong> Michelle Thoras, Corporate Sales Specialist – USA
Email:<\/strong> sales@radiantinsights.com
Phone:<\/strong> (415) 349-0054, Toll Free: 1-888-202-9519
Address:<\/strong>28 2nd Street, Suite 3036
City:<\/strong> San Francisco
State:<\/strong> California
Country:<\/strong> United States
Website:<\/strong> http:\/\/www.radiantinsights.com\/research\/alzheimer-s-disease-pipeline-review-h1-2016<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Radiant Insights” Research Report On “Alzheimer’s Disease” The report provides comprehensive information on the therapeutics under development for Alzheimer’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-61036","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/61036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=61036"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/61036\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=61036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=61036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=61036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}